Xemed LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.xemed.com
Clinical Trials
7
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:4
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (66.7%)Phase 2
2 (33.3%)Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation
Not yet recruiting
- Conditions
- COPD
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 10
- Registration Number
- NCT05816616
Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI
Phase 1
Recruiting
- Conditions
- COPD
- Interventions
- Drug: MagniXene Hyperpolarized Xenon MRI
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 100
- Registration Number
- NCT05433961
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
Phase 1
Terminated
- Conditions
- Carcinoma, Non-Small-Cell Lung
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 9
- Registration Number
- NCT05302817
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI
Phase 1
Recruiting
- Conditions
- Lung Transplant Rejection
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 90
- Registration Number
- NCT04941573
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
129Xe MRI in Pediatric Population With BPD
Phase 1
Not yet recruiting
- Conditions
- Bronchopulmonary Dysplasia
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 30
- Registration Number
- NCT04035629
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Prev
- 1
- 2
- Next
News
No news found